STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-08-16
Here’s whether Stryker Corporation (SYK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.15% over 10 days); RSI 51 — healthy momentum range; 3-month momentum positive (+10.6%). Concerns: trading below the 200-day MA (long-term downtrend); weak 1-year return of -10.4%. Currently 14.5% off its 52-week high. Score: +1/7.
SYK is trading below its 200-day MA ($341.33) — a key warning sign the longer-term trend is under pressure. An RSI of 51.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -10.4% compares to +20.4% for SPY (trailed the market by 30.8%).
$10,000 invested 1 year ago→ $8,961 today
vs. S&P 500 (SPY) — same period trailed market by 30.8%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($341.33)
✓Above 50-day MA ($324.02)
✓RSI(14) neutral zone (30–70) — currently 51.5
✗Positive return (-10.4%)
!Within 10% of period high (−14.5%)
Period Range $339.21
$281.00$396.86
RSI (14) 51.5
0 · OversoldOverbought · 100
Key Metrics
Price$339.21
Period Return-10.4%
Period High$396.86
Period Low$281.00
Drawdown−14.5%
MA-50$324.02
MA-200$341.33
RSI (14)51.5
Avg Volume (30d)2.4M
vs. SPYtrailed by 30.8%
Return Rank#790 of 1252
Trend Signals
Price is below the 200-day moving average ($341.33)
Price is above the 50-day moving average ($324.02)